loading page

ReGeneraTing Agents (RGTA®) technology combined with antibiotics improves outcomes for infections in the upper limb
  • Roohi Sharifah Ahmad,
  • Zela Keuylian,
  • Denis Barritault
Roohi Sharifah Ahmad
Universiti Putra Malaysia Fakulti Perubatan dan Sains Kesihatan
Author Profile
Zela Keuylian
OTR3
Author Profile
Denis Barritault
Organ, Tissue, Regenration, Repair, Replacement
Author Profile

Abstract

In this case series, four patients developed or presented with severe infections. In addition to antimicrobial therapy, they were treated with a new matrix therapy technology called CACIPLIQ20®. CACIPLIQ20® markedly improved the outcomes of all cases in terms of healing times and range of motion despite healing by secondary intention.

Peer review status:ACCEPTED

08 Jul 2020Submitted to Clinical Case Reports
09 Jul 2020Submission Checks Completed
09 Jul 2020Assigned to Editor
20 Jul 2020Reviewer(s) Assigned
11 Sep 2020Review(s) Completed, Editorial Evaluation Pending
11 Sep 2020Editorial Decision: Revise Minor
04 Nov 20201st Revision Received
06 Nov 2020Submission Checks Completed
06 Nov 2020Assigned to Editor
06 Nov 2020Review(s) Completed, Editorial Evaluation Pending
08 Nov 2020Editorial Decision: Accept